Lauren Krupp

Summary

Affiliation: State University of New York
Country: USA

Publications

  1. doi request reprint Multiple sclerosis-associated fatigue
    Lauren B Krupp
    Stony Brook University Medical Center, Department of Neurology, Stony Brook, NY 11794 8121, USA
    Expert Rev Neurother 10:1437-47. 2010
  2. ncbi request reprint Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial
    L B Krupp
    Department of Neurology, Stony Brook University Medical Center, Stony Brook, NY 11794 8121, USA
    Neurology 60:1923-30. 2003
  3. ncbi request reprint High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis
    Douglas E Gladstone
    Department of Medicine, State University of New York at Stony Brook, USA
    Arch Neurol 63:1388-93. 2006
  4. pmc Brief International Cognitive Assessment for MS (BICAMS): international standards for validation
    Ralph H B Benedict
    Buffalo General Medical Center, Department of Neurology, Suite E2, 100 High Street, Buffalo, NY 14203, USA
    BMC Neurol 12:55. 2012
  5. ncbi request reprint Managing MS. While a cure is sought, people with MS can help themselves
    Lauren Krupp
    Pediatric MS Center, Stony Brook University Medical Center, Long Island, New York, USA
    Health News 8:4. 2002
  6. ncbi request reprint Longitudinal neuropsychological assessment in pediatric multiple sclerosis
    William S MacAllister
    Department of Medicine, School of Neurology, State University of New York at Stony Brook, Stony Brook, NY, USA
    Dev Neuropsychol 32:625-44. 2007
  7. ncbi request reprint Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosis
    Christopher Christodoulou
    Department of Neurology, State University of New York at Stony Brook, Stony Brook, New York 11794 8121, USA
    J Int Neuropsychol Soc 11:614-9. 2005
  8. ncbi request reprint Effects of donepezil on memory and cognition in multiple sclerosis
    Christopher Christodoulou
    Department of Neurology, State University of New York, Stony Brook, HSC T12 020, 11794 8121, USA
    J Neurol Sci 245:127-36. 2006
  9. ncbi request reprint Multiple sclerosis-related fatigue
    William S MacAllister
    National Pediatric Multiple Sclerosis Center, State University of New York at Stony Brook, Stony Brook, NY 11794 8121, USA
    Phys Med Rehabil Clin N Am 16:483-502. 2005
  10. ncbi request reprint Fatigue in Parkinson's disease: a review
    Joseph H Friedman
    NeuroHealth, Warwick, Rhode Island 02886, USA
    Mov Disord 22:297-308. 2007

Research Grants

  1. NEUROBEHAVIORAL SYNDROME IN LATE BURGDORFERI INFECTION
    Lauren Krupp; Fiscal Year: 2001
  2. Assessment of Cognitive Dysfunction in MS
    Lauren Krupp; Fiscal Year: 2000
  3. Interventions to Improve Memory in MS Patients
    Lauren Krupp; Fiscal Year: 2000
  4. TREATMENT OF DESERT STORM SYNDROME
    Lauren Krupp; Fiscal Year: 2001
  5. CHRONIC FATIGUE IN POST LYME DISEASE
    Lauren Krupp; Fiscal Year: 2001
  6. Central Fatigue and Related Cognitive Function
    Lauren Krupp; Fiscal Year: 2001
  7. Cognitive Functioning Following Sleep Deprivation
    Lauren Krupp; Fiscal Year: 2000
  8. INTERVENTIONS TO IMPROVE MEMORY IN PATIENTS WITH MS
    Lauren Krupp; Fiscal Year: 2001
  9. CNS INVASION IN EARLY B BURGDORFERI INFECTION
    Lauren Krupp; Fiscal Year: 1999
  10. INTERVENTIONS TO IMPROVE MEMORY IN PATIENTS WITH MS
    Lauren Krupp; Fiscal Year: 2006

Collaborators

Detail Information

Publications12

  1. doi request reprint Multiple sclerosis-associated fatigue
    Lauren B Krupp
    Stony Brook University Medical Center, Department of Neurology, Stony Brook, NY 11794 8121, USA
    Expert Rev Neurother 10:1437-47. 2010
    ..Nonetheless, further research and the development of more targeted therapies are needed to improve the management of fatigue...
  2. ncbi request reprint Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial
    L B Krupp
    Department of Neurology, Stony Brook University Medical Center, Stony Brook, NY 11794 8121, USA
    Neurology 60:1923-30. 2003
    ..To determine whether post Lyme syndrome (PLS) is antibiotic responsive...
  3. ncbi request reprint High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis
    Douglas E Gladstone
    Department of Medicine, State University of New York at Stony Brook, USA
    Arch Neurol 63:1388-93. 2006
    ..High-dose cyclophosphamide is active in immune-mediated illnesses...
  4. pmc Brief International Cognitive Assessment for MS (BICAMS): international standards for validation
    Ralph H B Benedict
    Buffalo General Medical Center, Department of Neurology, Suite E2, 100 High Street, Buffalo, NY 14203, USA
    BMC Neurol 12:55. 2012
    ..At this time, preliminary studies are underway in a number of countries as we move forward with this international assessment tool for cognition in MS...
  5. ncbi request reprint Managing MS. While a cure is sought, people with MS can help themselves
    Lauren Krupp
    Pediatric MS Center, Stony Brook University Medical Center, Long Island, New York, USA
    Health News 8:4. 2002
  6. ncbi request reprint Longitudinal neuropsychological assessment in pediatric multiple sclerosis
    William S MacAllister
    Department of Medicine, School of Neurology, State University of New York at Stony Brook, Stony Brook, NY, USA
    Dev Neuropsychol 32:625-44. 2007
    ..The number of interim relapses (i.e., relapses occurring between baseline assessment and re-evaluation) showed a modest relationship to changes in cognitive function, but this did not reach statistical significance...
  7. ncbi request reprint Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosis
    Christopher Christodoulou
    Department of Neurology, State University of New York at Stony Brook, Stony Brook, New York 11794 8121, USA
    J Int Neuropsychol Soc 11:614-9. 2005
    ..Patients accurately perceived some changes in their level of cognitive dysfunction, though they were insensitive to the degree of their current dysfunction. Possible explanations of this pattern of results are discussed...
  8. ncbi request reprint Effects of donepezil on memory and cognition in multiple sclerosis
    Christopher Christodoulou
    Department of Neurology, State University of New York, Stony Brook, HSC T12 020, 11794 8121, USA
    J Neurol Sci 245:127-36. 2006
    ..Replication of results in a larger multi-center investigation is warranted in order to more definitively assess the efficacy of this intervention...
  9. ncbi request reprint Multiple sclerosis-related fatigue
    William S MacAllister
    National Pediatric Multiple Sclerosis Center, State University of New York at Stony Brook, Stony Brook, NY 11794 8121, USA
    Phys Med Rehabil Clin N Am 16:483-502. 2005
    ..The first-line agents include amantadine for mild fatigue and modafinil for more severe cases. Second-line agents include pemoline and antidepressant medications. Other pharmacologic agents have also shown some promise...
  10. ncbi request reprint Fatigue in Parkinson's disease: a review
    Joseph H Friedman
    NeuroHealth, Warwick, Rhode Island 02886, USA
    Mov Disord 22:297-308. 2007
    ..This article reviews what is known about the symptom, putting it into the context of fatigue in other disorders, and outlines a program for developing better understanding and therapy...
  11. ncbi request reprint Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option?
    Christopher Christodoulou
    Department of Neurology, State University of New York at Stony Brook, Stony Brook, New York 11794 8121, USA
    CNS Drugs 22:87-97. 2008
    ..On the whole, to date the research on AChEIs in MS must be considered preliminary, and it is premature to recommend the clinical use of this class of medications at the present time...
  12. ncbi request reprint Fatigue in multiple sclerosis: definition, pathophysiology and treatment
    Lauren B Krupp
    Department of Neurology, State University of New York at Stony Brook, New York, New York 11794, USA
    CNS Drugs 17:225-34. 2003
    ..Both medications have been studied with positive results in controlled clinical trials. Additional research towards measurement and pathogenesis of fatigue will hopefully lead to improved therapies...

Research Grants21

  1. NEUROBEHAVIORAL SYNDROME IN LATE BURGDORFERI INFECTION
    Lauren Krupp; Fiscal Year: 2001
    ..2. To determine the pathogenesis for neurobehavioral deficits in chronic Lyme disease. 3. To identify the clinical and laboratory factors which predict health outcome in chronic Lyme disease. ..
  2. Assessment of Cognitive Dysfunction in MS
    Lauren Krupp; Fiscal Year: 2000
    ..abstract_text> ..
  3. Interventions to Improve Memory in MS Patients
    Lauren Krupp; Fiscal Year: 2000
    ..It is hypothesized a greater proportion of MS patients treated with donepezil will show improvement in verbal memory that those treated with placebo. ..
  4. TREATMENT OF DESERT STORM SYNDROME
    Lauren Krupp; Fiscal Year: 2001
    ..Learning and memory measures include the Selective Reminding Test (SRT), and WMS-R Logical memory Test, and the Continuous Visual Memory test (CVMT). ..
  5. CHRONIC FATIGUE IN POST LYME DISEASE
    Lauren Krupp; Fiscal Year: 2001
    ..If no difference between antibiotic and placebo therapy is observed, this will be important objective data suggesting the inappropriateness of repeated courses of antibiotic therapy for PLS. ..
  6. Central Fatigue and Related Cognitive Function
    Lauren Krupp; Fiscal Year: 2001
    ..Using our model, we propose to define cognitive fatigue in two conditions in which cognitive dysfunction is a prominent feature: subjects with MS and healthy sleep-deprived subjects. ..
  7. Cognitive Functioning Following Sleep Deprivation
    Lauren Krupp; Fiscal Year: 2000
    ..abstract_text> ..
  8. INTERVENTIONS TO IMPROVE MEMORY IN PATIENTS WITH MS
    Lauren Krupp; Fiscal Year: 2001
    ..The investigators will also measure secondary outcomes assessing other areas of cognitive dysfunction (i.e., nonverbal memory, conceptual thinking, processing speed) which may improve with intervention. ..
  9. CNS INVASION IN EARLY B BURGDORFERI INFECTION
    Lauren Krupp; Fiscal Year: 1999
    ..The study parameters will include clinical features, immune response, cerebrospinal fluid changes, neurocognitive disturbances, and psychosocial aspects of the disease. ..
  10. INTERVENTIONS TO IMPROVE MEMORY IN PATIENTS WITH MS
    Lauren Krupp; Fiscal Year: 2006
    ..Specific Aim 2: To examine the relationship of treatment response to baseline subject characteristics, such as baseline neuropsychological performance, and MS subtype. ..